Sponsor pipeline

Phanes Therapeutics clinical trial pipeline

Get alerts when Phanes Therapeutics's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor

    Enrollment increased: 258 → 350 participants

    Also in this update: Interventions modified

    Phanes TherapeuticsPhase 1/2 NCT05482893 Registry history

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1/2
3

Disease areas by active trials

Lung Cancer (2) · Pancreatic Cancer (2) · Cholangiocarcinoma (1) · Colorectal Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1) · Prostate Cancer (1) · Small Cell Lung Cancer (1)

Get alerts when Phanes Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free